Global Botulism Illness Market Size, Status and Forecast 2020-2026

May 2020 | 96 pages | ID: G8B09632CDE0EN
QYResearch

Abstracts

This report focuses on the global Botulism Illness status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Botulism Illness development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Microbiotix
• XOMA Corporation
• Molecular Targeting Technologies
• AlphaVax
• Morphotek
• ...

Market segment by Type, the product can be split into

• Antibiotics
• Antitoxins
• Other

Market segment by Application, split into

• Hospitals
• Clinics
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Botulism Illness status, future forecast, growth opportunity, key market and key players.
• To present the Botulism Illness development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Botulism Illness are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Botulism Illness Revenue
1.4 Market Analysis by Type
  1.4.1 Global Botulism Illness Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Antibiotics
  1.4.3 Antitoxins
  1.4.4 Other
1.5 Market by Application
  1.5.1 Global Botulism Illness Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Botulism Illness Market Perspective (2015-2026)
2.2 Botulism Illness Growth Trends by Regions
  2.2.1 Botulism Illness Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Botulism Illness Historic Market Share by Regions (2015-2020)
  2.2.3 Botulism Illness Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Botulism Illness Market Growth Strategy
  2.3.6 Primary Interviews with Key Botulism Illness Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Botulism Illness Players by Market Size
  3.1.1 Global Top Botulism Illness Players by Revenue (2015-2020)
  3.1.2 Global Botulism Illness Revenue Market Share by Players (2015-2020)
  3.1.3 Global Botulism Illness Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Botulism Illness Market Concentration Ratio
  3.2.1 Global Botulism Illness Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Botulism Illness Revenue in 2019
3.3 Botulism Illness Key Players Head office and Area Served
3.4 Key Players Botulism Illness Product Solution and Service
3.5 Date of Enter into Botulism Illness Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Botulism Illness Historic Market Size by Type (2015-2020)
4.2 Global Botulism Illness Forecasted Market Size by Type (2021-2026)

5 BOTULISM ILLNESS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Botulism Illness Market Size by Application (2015-2020)
5.2 Global Botulism Illness Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Botulism Illness Market Size (2015-2020)
6.2 Botulism Illness Key Players in North America (2019-2020)
6.3 North America Botulism Illness Market Size by Type (2015-2020)
6.4 North America Botulism Illness Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Botulism Illness Market Size (2015-2020)
7.2 Botulism Illness Key Players in Europe (2019-2020)
7.3 Europe Botulism Illness Market Size by Type (2015-2020)
7.4 Europe Botulism Illness Market Size by Application (2015-2020)

8 CHINA

8.1 China Botulism Illness Market Size (2015-2020)
8.2 Botulism Illness Key Players in China (2019-2020)
8.3 China Botulism Illness Market Size by Type (2015-2020)
8.4 China Botulism Illness Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Botulism Illness Market Size (2015-2020)
9.2 Botulism Illness Key Players in Japan (2019-2020)
9.3 Japan Botulism Illness Market Size by Type (2015-2020)
9.4 Japan Botulism Illness Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Botulism Illness Market Size (2015-2020)
10.2 Botulism Illness Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Botulism Illness Market Size by Type (2015-2020)
10.4 Southeast Asia Botulism Illness Market Size by Application (2015-2020)

11 INDIA

11.1 India Botulism Illness Market Size (2015-2020)
11.2 Botulism Illness Key Players in India (2019-2020)
11.3 India Botulism Illness Market Size by Type (2015-2020)
11.4 India Botulism Illness Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Botulism Illness Market Size (2015-2020)
12.2 Botulism Illness Key Players in Central & South America (2019-2020)
12.3 Central & South America Botulism Illness Market Size by Type (2015-2020)
12.4 Central & South America Botulism Illness Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Microbiotix
  13.1.1 Microbiotix Company Details
  13.1.2 Microbiotix Business Overview and Its Total Revenue
  13.1.3 Microbiotix Botulism Illness Introduction
  13.1.4 Microbiotix Revenue in Botulism Illness Business (2015-2020))
  13.1.5 Microbiotix Recent Development
13.2 XOMA Corporation
  13.2.1 XOMA Corporation Company Details
  13.2.2 XOMA Corporation Business Overview and Its Total Revenue
  13.2.3 XOMA Corporation Botulism Illness Introduction
  13.2.4 XOMA Corporation Revenue in Botulism Illness Business (2015-2020)
  13.2.5 XOMA Corporation Recent Development
13.3 Molecular Targeting Technologies
  13.3.1 Molecular Targeting Technologies Company Details
  13.3.2 Molecular Targeting Technologies Business Overview and Its Total Revenue
  13.3.3 Molecular Targeting Technologies Botulism Illness Introduction
  13.3.4 Molecular Targeting Technologies Revenue in Botulism Illness Business (2015-2020)
  13.3.5 Molecular Targeting Technologies Recent Development
13.4 AlphaVax
  13.4.1 AlphaVax Company Details
  13.4.2 AlphaVax Business Overview and Its Total Revenue
  13.4.3 AlphaVax Botulism Illness Introduction
  13.4.4 AlphaVax Revenue in Botulism Illness Business (2015-2020)
  13.4.5 AlphaVax Recent Development
13.5 Morphotek
  13.5.1 Morphotek Company Details
  13.5.2 Morphotek Business Overview and Its Total Revenue
  13.5.3 Morphotek Botulism Illness Introduction
  13.5.4 Morphotek Revenue in Botulism Illness Business (2015-2020)
  13.5.5 Morphotek Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Botulism Illness Key Market Segments
Table 2. Key Players Covered: Ranking by Botulism Illness Revenue
Table 3. Ranking of Global Top Botulism Illness Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Botulism Illness Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antibiotics
Table 6. Key Players of Antitoxins
Table 7. Key Players of Other
Table 8. Global Botulism Illness Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Botulism Illness Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Botulism Illness Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Botulism Illness Market Share by Regions (2015-2020)
Table 12. Global Botulism Illness Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Botulism Illness Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Botulism Illness Market Growth Strategy
Table 18. Main Points Interviewed from Key Botulism Illness Players
Table 19. Global Botulism Illness Revenue by Players (2015-2020) (Million US$)
Table 20. Global Botulism Illness Market Share by Players (2015-2020)
Table 21. Global Top Botulism Illness Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Botulism Illness as of 2019)
Table 22. Global Botulism Illness by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Botulism Illness Product Solution and Service
Table 25. Date of Enter into Botulism Illness Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Botulism Illness Market Size by Type (2015-2020) (Million US$)
Table 28. Global Botulism Illness Market Size Share by Type (2015-2020)
Table 29. Global Botulism Illness Revenue Market Share by Type (2021-2026)
Table 30. Global Botulism Illness Market Size Share by Application (2015-2020)
Table 31. Global Botulism Illness Market Size by Application (2015-2020) (Million US$)
Table 32. Global Botulism Illness Market Size Share by Application (2021-2026)
Table 33. North America Key Players Botulism Illness Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Botulism Illness Market Share (2019-2020)
Table 35. North America Botulism Illness Market Size by Type (2015-2020) (Million US$)
Table 36. North America Botulism Illness Market Share by Type (2015-2020)
Table 37. North America Botulism Illness Market Size by Application (2015-2020) (Million US$)
Table 38. North America Botulism Illness Market Share by Application (2015-2020)
Table 39. Europe Key Players Botulism Illness Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Botulism Illness Market Share (2019-2020)
Table 41. Europe Botulism Illness Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Botulism Illness Market Share by Type (2015-2020)
Table 43. Europe Botulism Illness Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Botulism Illness Market Share by Application (2015-2020)
Table 45. China Key Players Botulism Illness Revenue (2019-2020) (Million US$)
Table 46. China Key Players Botulism Illness Market Share (2019-2020)
Table 47. China Botulism Illness Market Size by Type (2015-2020) (Million US$)
Table 48. China Botulism Illness Market Share by Type (2015-2020)
Table 49. China Botulism Illness Market Size by Application (2015-2020) (Million US$)
Table 50. China Botulism Illness Market Share by Application (2015-2020)
Table 51. Japan Key Players Botulism Illness Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Botulism Illness Market Share (2019-2020)
Table 53. Japan Botulism Illness Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Botulism Illness Market Share by Type (2015-2020)
Table 55. Japan Botulism Illness Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Botulism Illness Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Botulism Illness Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Botulism Illness Market Share (2019-2020)
Table 59. Southeast Asia Botulism Illness Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Botulism Illness Market Share by Type (2015-2020)
Table 61. Southeast Asia Botulism Illness Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Botulism Illness Market Share by Application (2015-2020)
Table 63. India Key Players Botulism Illness Revenue (2019-2020) (Million US$)
Table 64. India Key Players Botulism Illness Market Share (2019-2020)
Table 65. India Botulism Illness Market Size by Type (2015-2020) (Million US$)
Table 66. India Botulism Illness Market Share by Type (2015-2020)
Table 67. India Botulism Illness Market Size by Application (2015-2020) (Million US$)
Table 68. India Botulism Illness Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Botulism Illness Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Botulism Illness Market Share (2019-2020)
Table 71. Central & South America Botulism Illness Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Botulism Illness Market Share by Type (2015-2020)
Table 73. Central & South America Botulism Illness Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Botulism Illness Market Share by Application (2015-2020)
Table 75. Microbiotix Company Details
Table 76. Microbiotix Business Overview
Table 77. Microbiotix Product
Table 78. Microbiotix Revenue in Botulism Illness Business (2015-2020) (Million US$)
Table 79. Microbiotix Recent Development
Table 80. XOMA Corporation Company Details
Table 81. XOMA Corporation Business Overview
Table 82. XOMA Corporation Product
Table 83. XOMA Corporation Revenue in Botulism Illness Business (2015-2020) (Million US$)
Table 84. XOMA Corporation Recent Development
Table 85. Molecular Targeting Technologies Company Details
Table 86. Molecular Targeting Technologies Business Overview
Table 87. Molecular Targeting Technologies Product
Table 88. Molecular Targeting Technologies Revenue in Botulism Illness Business (2015-2020) (Million US$)
Table 89. Molecular Targeting Technologies Recent Development
Table 90. AlphaVax Company Details
Table 91. AlphaVax Business Overview
Table 92. AlphaVax Product
Table 93. AlphaVax Revenue in Botulism Illness Business (2015-2020) (Million US$)
Table 94. AlphaVax Recent Development
Table 95. Morphotek Company Details
Table 96. Morphotek Business Overview
Table 97. Morphotek Product
Table 98. Morphotek Revenue in Botulism Illness Business (2015-2020) (Million US$)
Table 99. Morphotek Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Botulism Illness Market Share by Type: 2020 VS 2026
Figure 2. Antibiotics Features
Figure 3. Antitoxins Features
Figure 4. Other Features
Figure 5. Global Botulism Illness Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Botulism Illness Report Years Considered
Figure 10. Global Botulism Illness Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Botulism Illness Market Share by Regions: 2020 VS 2026
Figure 12. Global Botulism Illness Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Botulism Illness Market Share by Players in 2019
Figure 15. Global Top Botulism Illness Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Botulism Illness as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Botulism Illness Revenue in 2019
Figure 17. North America Botulism Illness Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Botulism Illness Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Botulism Illness Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Botulism Illness Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Botulism Illness Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Botulism Illness Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Botulism Illness Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Microbiotix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Microbiotix Revenue Growth Rate in Botulism Illness Business (2015-2020)
Figure 26. XOMA Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. XOMA Corporation Revenue Growth Rate in Botulism Illness Business (2015-2020)
Figure 28. Molecular Targeting Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Molecular Targeting Technologies Revenue Growth Rate in Botulism Illness Business (2015-2020)
Figure 30. AlphaVax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. AlphaVax Revenue Growth Rate in Botulism Illness Business (2015-2020)
Figure 32. Morphotek Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Morphotek Revenue Growth Rate in Botulism Illness Business (2015-2020)
Figure 34. Bottom-up and Top-down Approaches for This Report
Figure 35. Data Triangulation
Figure 36. Key Executives Interviewed